{"denoms":[{"counts":[{"groupId":"BG000","value":"268"},{"groupId":"BG001","value":"117"},{"groupId":"BG002","value":"385"}],"units":"Participants"}],"groups":[{"description":"Patients with high risk prostate cancer planned for radical prostatectomy with pelvic lymph node dissection were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.","id":"BG000","title":"High Risk Prostate Cancer (Cohort A)"},{"description":"Patients with presumptive radiologic evidence of prostate cancer recurrence or metastasis on conventional imaging and planned for conventional image-guided biopsy were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.","id":"BG001","title":"Recurrent or Metastatic Prostate Cancer (Cohort B)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"46","upperLimit":"84","value":"65"},{"groupId":"BG001","lowerLimit":"45","upperLimit":"86","value":"68"},{"groupId":"BG002","lowerLimit":"45","upperLimit":"86","value":"66"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"268"},{"groupId":"BG001","value":"117"},{"groupId":"BG002","value":"385"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"233"},{"groupId":"BG001","value":"101"},{"groupId":"BG002","value":"334"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"29"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"11"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}],"title":"Other"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"}],"title":"Unknown or Not Reported"}],"title":"Race"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"Safety population; total number of patients who received 18F-DCFPyL injection."}